Calidi Biotherapeutics Receives FDA Clearance for Innovative Cancer Therapy
April 17, 2025 — Calidi Biotherapeutics receives FDA clearance for CLD-201, a stem cell-based virotherapy targeting solid tumors, offering hope for hard-to-treat cancers. InvestorWire's press release syndication highlights the breakthrough in cancer treatment, emphasizing the importance of communicating such advancements to the investment community.